Iwasaki H, Nishi K, Imai T, Yasukawa D, Chatani M, Matsuda S, Ohno M, Nishi E. Nardilysin in hepatocyte regulates adaptive thermogenesis in brown adipose tissue through the control of skin blood flow.
Osamu Baba. CXCR4-binding tracers link monocyte recruitment and endothelial injury at atherosclerosis.
第42回日本血栓止血学会学術集会 2020年6月18日 -20日, 誌上開催・web.
山下 侑吾. Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.
Takeshi Kimura. Main Results from the CREDO-Kyoto Cohort-3 in the New Generation DES Era.
Takeshi Kimura. Section 1. Position Statement.
Koh Ono. Section 1. Conclusions.
Koh Ono. Section 2. Backgrounds.
Koh Ono. Role of microRNAs in Cardiovascular Disease.
Koh Ono. Controversies in primary prevention We should move to lower target blood pressure (SBP<130).
静田 聡. Recent Advances and Clinical Benefits of Catheter Ablation for Atrial Fibrillation .
静田 聡. 私はこの不整脈をこう診断する!
静田 聡. Section 1. エキスパートオピニオン.
Satoshi Shizuta. Section 1. Opening Lecture.
Satoshi Shizuta. Section 2. Pros: Yes. Patients Undergoing Catheter Ablation for AF is Associated with Very Low Risk of Stroke Regardless of AF Symptoms.
Satoshi Shizuta. Section 3. Backgrounds.
Satoshi Shizuta. The Elderly Patient with Renal Failure.
齋藤 成達. Section 4. エキスパートオピニオン.
齋藤 成達. 井上先生へのメッセージ(ビデオレターfrom Bangladesh, Kenya, USA, etc).
中川 靖章. Structure of Glycosylation Attached to N-terminal Region of proBNP Importance of Processing of proBNP in Heart Failure.
木下 秀之. ACHD-PAHの治療例の実際 効果判定とpitfall.
木下 秀之. Section 3. エキスパートオピニオン.
木下 秀之. 肺高血圧診療のpitfall.
Takeru Makiyama. Commentary.
Takeru Makiyama. Cardiac Arrhythmias.
小笹 寧子. 慢性心不全患者の栄養管理・総論.
小笹 寧子. エキスパートオピニオン.
小笹 寧子. 血糖降下薬を始める前に.
小笹 寧子. 左室機能低下に合併した重症僧帽弁逆流をどうする?.
Neiko Ozasa. Neiko Ozasa, Saeko Imai, Shizuo Kajiyama, Takeshi Kimura. Change practice in primary and secondary prevention Management of diabetes should be drastically changed from pharmacologic glucose-centric approach to intensive life style changes focusing on patients-centric outcomes.
Neiko Ozasa, Takao Katoh, Takeshi Morimoto, Hidenori Yaku, Erika Yamamoto, Yasutaka Inuzuka, Yodo Tamaki, Yusuke Yoshikawa, Yukihito Satoh, Koichiro Kuwahara, Takeshi Kimura. The Impact of Multiple Medications on Long-term Prognosis in Patients with Acute Decompensated HF-insights from the KCHF Registry.
堀江 貴裕, 小山 智史, 木村 剛, 尾野 亘. miR-33b Has More Impact on The Formation of Insulin Resistance and Atherosclerosis than miR-33a.
Takahiro Horie. High-intency Statins Work Regardless of Age.
Hiroki Shiomi. OPTIVUS-complex PCI Study: Study Design and Expectations.
Hiroki Shiomi. Overview of CREDO-Kyoto Registries.
Hiroki Shiomi. Trends in Management and Long-term Outcome in Coronary Revascularization over Recent Decades in Japan: Insight from the CREDO-Kyoto Registry Cohort-1, 2, and 3.
田崎 淳一. Section 2. Pros: Yes, EVAR is the First Line Therapy for AAA.
田崎 淳一. Section 3. Pros: Yes, We should Consider Earlier Aortic Aneurysm Repair for Asian Population than for Western Population.
田崎 淳一. 私はこの左主幹部分岐部症例をこう治療する -2.
Junichi Tazaki. Section 2. Conclusion.
Junichi Tazaki. Efficacy and Safety of Endovascular Repair for Abdominal and Thoracic Aortic Aneurysms, a Prospective Multicenter Observational Study in Japan.
渡邉 真. Section 1. Backgrounds.
渡邉 真. Opening.
渡邉 真. Section 2. エキスパートオピニオン.
Shin Watanabe, Hirotoshi Watanabe, Junichi Tazaki, Takeshi Kimura, Hisanori Horiuchi. Acquired von Willebrand Syndrome on Percutaneous Ventricular Assist Device (IMPELLA).
渡部 宏俊. Optimal DAPT Duration in Patients with High Bleeding Risk ~ Insights from the STOPDAPT-2 Trial .
渡部 宏俊. STOPDAPT-2とDAPT期間に関する最近の話題.
Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, Masahiro Natsuaki, Hiroki Shiomi, Toshiaki Toyota, Masanobu Ohya, Satoru Suwa, Kenji Ando, Yoshihiro Morino, Ken Kozuma, Kazushige Kadota, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura. Very Short Dual Antiplatelet Therapy in Patients with High Bleeding Risk.
Hirotoshi Watanabe. Section 1. Opening Lecture.
Hirotoshi Watanabe. Section 1. Conclusions.
Hirotoshi Watanabe. Section 3. Conclusions.
Hirotoshi Watanabe. Very Short DAPT in Patients Who Underwent Complex PCI: From the STOPDAPT-2.
Hirotoshi Watanabe. Balance between Ischemic and Bleeding Risks in Japan.
加藤 貴雄. Section 3. Conclusion.
加藤 貴雄. Temporal and Spatial Analysis of Organ Interaction: A Message from Multiomics Science.
加藤 貴雄, 上村 夕香理, 納谷 昌直, 松本 直也, 百瀬 満, 肥田 敏, 山内 貴雄, 中島 崇智, 鈴木 絵里子, 志賀 哲, 玉木 長良. Impact of Renal Dysfunction on the Choice of Diagnostic Imaging and Outcomes in Patients with Stable Angina.
Takao Kato. Keynote Lecture Nutrition and heart failure.
Takao Kato. Mechanism of Downward Spiral in Patients with Atrial Fibrillation and Heart Failure.
Takao Kato. JCS Guidelines Expert Comment.
Takao Kato, Yukari Uemura, Masanao Naya, Naoya Matsumoto, Mitsuru Momose, Satoshi Hida, Takao Yamauchi, Takatomo Nakajima, Tohru Shiga, Nagara Tamaki. Impact of Revascularization on Outcomes was not Different between SPECT First and CT First Strategies for Suspected Coronary Artery Disease.
加藤 恵理. そうはいっても実際の血糖管理をどうする.
Eri Kato. Section 1. Opening Lecture.
Eri Kato. Do We Need Different Strategy for Patients with Diabetes and HFpEF?
Eri Kato, Hiroki Shiomi, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura. Impact of HFpEF and HFrEF in Patients with or without Diabetes after Coronary Revascularization; Analysis from the CREDO-Kyoto Registry Cohort-2.
Osamu Baba, Andrew Elvington, Deborah Sultan, Gyu Seong Heo, Xiaohui Zhang, Hannah Luehmann, Lisa Detering, Martyna Szpakowska, Andy Chevigne, Yongjian Liu, Gwendalyn Randolph. CXCR4 on Atherosclerotic Plaque Endothelium Predicts the Magnitude of Monocyte Recruitment and is Readily Targeted by PET Tracers.
Osamu Baba, Deborah Sultan, Gyu Seong Heo, Xiaohui Zhang, Hannah Luehmann, Lisa Detering, Yongjian Liu, Gwendalyn Randolph. The CCR2 Targeting Peptide-based PET Tracer,64Cu-DOTA-ECL1i can Non-invasively Visualize Monocytes and Inflammatory Macrophages in Atherosclerotic Plaque.
Erika Yamamoto, Takao Katoh, Takeshi Morimoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Yukihito Satoh, Koichiro Kuwahara, Takeshi Kimura. Impact of Appetite Loss at Discharge on the Prognosis in Patients with Acute Decompensated Heart Failure.
Shintaro Matsuda, Kiyoto Nishi, Mikiko Ohno, Eiichiro Nishi. Nardilysin in Adipocyte Regulates Adipose Tissue Inflammation and Insulin Sensitivity.
南野 ( 牟田 ) 恵里. Risk Stratification and Follow-up of Patients with Asymptomatic Severe Aortic Stenosis.
南野 恵里, 加藤 貴雄, 森本 剛, 谷口 智彦, 木村 剛. Decline in Left Ventricular Ejection Fraction during Follow-up in Patients with Severe Aortic Stenosis.
糀谷 泰彦, 柏 麻美, 野間 昭典, 牧山 武, 豊田 太, 山本 雄大, 烏日揚海 伊敏, 堀江 稔, 大野聖子 高 景山, 黄 海, 今村 知彦, 相澤 卓範, 静田 聡, 木村 剛. Usefulness of Combination of Mathematical Modeling and Cell Engineering Using Induced Pluripotent Stem Cells for Revealing Complex Disease Mechanism.
Hirohiko Kohjitani, Takeru Makiyama, Yuta Yamamoto, Wuriyanghai Yimin, Daisuke Yoshinaga, Asami Kashiwa, Tomohiko Imamura,Takanori Aizawa,Jingshan Gao,Hai Huang,Satoshi Shizuta,Takeshi Kimura.Artificial Intelligence Based Optimization System for Cell-specific hiPSC-CMs Simulation and Prediction of Drug Testing.
夜久 英憲. 循環器疾患に対する漢方治療の展望 これから始まる心不全漢方多施設共同臨床研究の紹介.
Hidenori Yaku. Section 1. Pros: Yes, but How Long?
Hidenori Yaku. Messages from KCHF.
山下 侑吾, 森本 剛, 木村 剛. The Current Issues and Future Perspective of Clinical Trials under Clinical Trials Act: Experiences from ONCO DVT Study.
山下 侑吾. Section 1. Backgrounds.
山下 侑吾. 静脈血栓塞栓症の外来治療.
山下 侑吾. がん関連血栓症 .
山下 侑吾. DOAC 時代における静脈血栓塞栓症の外来治療.
Yugo Yamashita. The Current Status of Venous Thromboembolism in Japan: Insight from a Nationwide Claim-Based Database, JROAD-DPC Study.
Yugo Yamashita, Takeshi Morimoto, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kite Kim, Koh Ono, Takeshi Kimura. Utility of Simplified PESI Score for Identification of Low-risk Pulmonary Embolism Patients with Active Cancer: From the COMMAND VTE Registry.
Yugo Yamashita, Hisashi Ogawa, Takeshi Morimoto, Mitsuru Abe, Masaharu Akao, Takeshi Kimura. The Differences in Clinical Characteristics between Atrial Fibrillation and Venous Thromboembolism: From Fushimi AF Registry and COMMAND VTE Registry.
Shintaro Yamagami. The Low Left Atrial Appendage Flow Velocity as a Risk of Thromboembolic Events after Catheter Ablation for Atrial Fibrillation.
嶋本 光兵. 症例提示:多剤内服でも血糖管理目標に及ばず主治医に叱責され落ち込む糖尿病患者.
嶋本 光兵. Section 3. 症例提示(前半).
嶋本 光兵. Section 3. 症例提示(後半).
鮑 炳元. Section 3. 症例提示(前半).
鮑 炳元. Section 3. 症例提示(後半).
Takafumi Kawai, Noboru Ashida, Takeshi Kimura. Deletion of IKK Β in Myofibroblasts Augments Cardiac Fibrosis after Myocardial Infarction.
杉岡 紗千子, 芦田 昇, 木村 剛. Activated NF- Κ B Signaling Both in Cardiomyocytes and Cardiac Fibroblasts Induces Non-compaction Cardiomyopathy.
Yukiko Nakano. Section 3. Openig Lecture.
Yukiko Nakano. Section 2. Backgrounds.
Yukiko Nakano. Comparison of Clinical Outcomes after PCI and CABG in Patients with Triple Vessel Disease from the CREDO-Kyoto Registry Cohort-3.
Shuhei Tsuji, Yasuhide Kuwabara, Takahiro Horie, Takeshi Kimura, Koh Ono. Long Intergenic Noncoding RNA, Lionheart, Regulates Heart Size and Contributes to the Protection from Pressure Overload Induced Heart Failure.
Manabu Kasamoto, Takeshi Hatani, Shunsuke Funakoshi, Yoshinori Yoshida, Takeshi Kimura. Achievement of Efficient iPS-cell Derived Cardiomyocyte Engraftment by Activating Cell Cycle with the Brand-new Compound.
柏 麻美, 牧山 武, Thomas Maurissen, 糀谷 泰彦, Yimin Wuriyanghai, 山本 雄大, Jingshan Gao, Hai Huang, 今村 知彦, 相澤 卓範, 石川 泰輔, 大野 聖子, 豊田 太, 佐藤 誠一, 高橋 一浩, Knut Woltjen, 堀江 稔, 蒔田 直昌, 木村 剛. OJ31-2 Human Induced Pluripotent Stem Cell Model of CACNA1C-E1115K which Impairs Ion Selectivity of the Cardiac L-type Calcium Channel.
竹治 泰明. Is the Patient Truly Asymptomatic?
Yasuaki Takeji. Outcomes of ACS with Cardiogenic Shock Undergoing Primary PCI in Japan.
Yasuaki Takeji. K-TAVI Registry.
Yasuaki Takeji. CURRENT AS Registry-2; Study Design and Objectives.
Yasuaki Takeji. Trends in Practice Pattern and Clinical Outcomes in Acute Myocardial Infarction from the CREDO-Kyoto AMI Registry Wave-1 (2005-2007) to Wave-2 (2011-2013).
Yasuaki Takeji. Clinical Outcome after Surgical Aortic Valve Replacement in Low-Surgical Risk-Japanese Patients with Severe Aortic Stenosis: From the CURRENT AS Registry.
脊古 裕太, 加藤 貴雄, 柴 昌行, 森田 雄介, 山地 雄平, 中根 英策, 春名 克純, 春名 徹也, 猪子森明. Association of the e’ and E/e’ with Long-term Outcomes in Patients with Normal Ejection Fraction.
Yuta Seko, Takao Katoh, Moriaki Inoko, Takeshi Kimura. Staging Cardiac Damage in Patients with Hypertension.
山本 航. Application of Procedural Complexity Criteria in an All-comes Registry of Percutaneous Coronary Intervention.
山本 航. 症例提示(前半)・オーディエンスレスポンス.
山本 航. 症例提示(後半)・オーディエンスレスポンス.
Ko Yamamoto.Section 2. Opening Lecture.
Ko Yamamoto. Comparison of Clinical Outcomes after PCI and CABG in Patients with Left Main Coronary Artery Disease from the CREDO-Kyoto Registry Cohort-3.
Ko Yamamoto. Impact of Body Weight on Clinical Outcomes after PCI: From the CREDO- Kyoto Registry.
Xiaoyang Song, Naritatsu Saitoh, Takao Katoh, Tomohiko Taniguchi, Shinichi Shirai, Takeshi Kimura. The Impact of Diabetes Mellitus on Conservatively Managed Patients with Severe Aortic Stenosis.
Yuta Yamamoto, Takeru Makiyama, Yimin Wuriyanghai, Hirohiko Kohjitani, Sayako Hirose, Jingshan Gao, Asami Kashiwa, Hai Huang, Takanori Aizawa, Tomohiko Imamura, Taisuke Ishikawa, Yoshinori Yoshida, Seiko Ohno, Minoru Horie, Naomasa Makita, Takeshi Kimura. CALM2-N98S Mutation Associated with Long QT Syndrome Impaired the Response of KCNQ1 Channel to Beta-adrenergic Stimulation in Human iPSC-derived Cardiomyocytes.
Yusuke Yoshikawa. Clinical Outcomes after PCI Using 1st and 2nd Generation DES: Insight from the CREDO-Kyoto Registry Cohort-2 and -3.
Yoshinori Yoshida. Development of Cardiac Regeneration Using Highly Engraftable Cardiomyocytes.
Yoshinori Yoshida. Single Cell Analysis Using iPS Derived Cardiomyocytes.
Yoshinori Yoshida. Targeted Disruption of HLA Genes for Clinical Application of iPSCs.
Takeshi Hatani, Chikako Okubo, Yoshihiko Fujita, Kazuhisa Chonabayashi, Takeshi Kimura, Hirohide Saito, Yoshinori Yoshida. Efficient Large-scale Purification of Human iPSC-derived Cardiomyocytes by Synthetic MicroRNA Switch and Magnetic-activated Cell Sorting.
Katsuhisa Ishii, Yusuke Yoshikawa, Eiichi Hyodo, Yoshihiro Seo, Hajime Kihara, Hiroyuki Watanabe, Masao Daimon, Atsushi Tanaka, Takashi Akasaka, Hiroshi Ito. Two-dimensional Speckle Tracking Echocardiography for Diagnosing Chest Pain in the Emergency Room: The Multicenter Prospective Study by A TRAC-SI Group.
Maki Oi, Yugo Yamashita, Takeshi Morimoto, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kite Kim, Yohei Kobayashi, Tomohisa Tada, Koichiro Murata, Yoshiaki Tsuyuki, Mamoru Toyofuku, Toshikazu Jinnai, Kazuaki Kaitani, Takeshi Kimura. Anticoagulation Therapy and Outcomes of Venous Thromboembolism According to with or without Atrial Fibrillation: From the COMMAND VTE Registry.
Maki Oi, Mamoru Toyofuku, Yugo Yamashita, Takeshi Morimoto, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kite Kim, Yohei Kobayashi, Tomohisa Tada, Yasuyo Motohashi, Takashi Tamura, Takeshi Kimura. Influence of D-dimer Levels on Long-term Clinical Outcomes in Cancer-associated Venous Thromboembolism: From the COMMAND VTE Registry.
Chikako Okubo ,Yoshinori Yoshida. Profiling HAND1 and HAND2 Expressions during Cardiogenesis Using hiPSCs.
Mikiko Ohno, Kiyoto Nishi, Shinichiro Niizuma, Shintaro Matsuda, Hirotaka Iwasaki, Takeshi Kimura, Eiichiro Nishi. Nardilysin Controls Cardiac Sympathetic Innervation Patterning via Cleavage of the p75 Neurotrophin Receptor.
Mikiko Ohno, Kiyoto Nishi, Shinichiro Niizuma, Shintaro Matsuda, Hirotaka Iwasaki, TakeshiKimura, Eiichiro Nishi. Nardilysin Controls Cardiac Sympathetic Innervation Patterning via Cleavage of the p75 Neurotrophin Receptor.
Mikiko Ohno, Hiroshi Matsuura, Takeru Makiyama, Hirohiko Kohjitani, Kiyoto Nishi, Hirotaka Iwasaki, Shintaro Matsuda, Takeshi Kimura, Eiichiro Nishi. Metalloprotease Nardilysin Controls Heart Rate through the Transcriptional Regulation of Ion Channels Critical for Sinus Automaticity.
大野 美紀子. 心筋症 2 Biomarkers and molecular mechanism.
奥村 謙, 稲葉 理, 合屋 雅彦, 静田 聡, 沖重 薫, 栗田 隆志, 熊谷 浩一郎, 古山 准二郎, 廣島 謙一, 小堀 敦志, 木村 正臣, 新田 順一. Procedural Outcomes and Safety using Cryoballoon for Atrial Fibrillation Ablation: Japan Cohort Results from the Cryo AF Global Registry.
貝谷 和昭, 小堀 敦志, 井上 耕一, 森島 逸郎, 草野 研吾, 静田 聡. The Difference of Long-term Outcome by Antiarrhythmic Drug after Ablation for Paroxysmal Atrial Fibrillation; Sub-analysis of EAST-AF Trial.
木村 祐樹, 猪子 森明, 加藤 貴雄. The Fundamental Changes in Cardiac Function and Biomarkers during the Normal Peripartum Period.
Misato Koakutsu, Kenji Miki, Tomoyuki Nishimoto, Yoshinori Yoshida. Identification of a Cell Surface Marker for Isolation of hiPSC-derived Ventricular and Atrial Cardiomyocytes.
Jiro Sakamoto, Yugo Yamashita, Takeshi Morimoto, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kite Kim, Koh Ono, Takeshi Kimura. Clinical Characteristics and Outcomes According to Cancer Sites in Patients with Cancer-Associated Venous Thromboembolism: From COMMAND VTE Registry.
Tomohisa Tada, Kotaro Takahashi, Yugo Yamashita, Takeshi Morimoto, Hiroki Sakamoto, Takeshi Kimura. Anticoagulation Therapy and Clinical Outcomes among Elderly Patients after Venous Thromboembolism: From the COMMAND VTE Registry.
Tomohiko Taniguchi, Takeshi Morimoto, Hiroki Shiomi, Kenji Ando, Shinichi Shirai, Norio Kanamori, Koichiro Murata, Takeshi Kitai, Yuichi Kawase, Kazushige Kadota, Makoto Miyake, Chisato Izumi, Eri Minamino, Takao Katoh, Katsuhisa Ishii, Kazuya Nagao, Naritatsu Saitoh, Kenji Minatoya, Takeshi Kimura. Elective Non-cardiac Surgery in Patients with Severe Aortic Stenosis: Observations from the CURRENT AS Registry.
田巻 庸道, 夜久 英憲, 山本 絵里香, 小笹 寧子, 犬塚 康孝, 近藤 博和, 田村 俊寛, 森本 剛, 中川 義久, 加藤 貴雄, 木村 剛. Prognostic Impact of Hyponatremia during Hospitalization in Patients with Acute Decompensated Heart Failure.
Toshiaki Toyota, Takeshi Morimoto, Satoshi Shizuta, Hirotoshi Watanabe, Hiroki Shiomi, Takao Katoh, Takeru Makiyama, Yasuaki Nakagawa, Naritatsu Saitoh, Koh Ono, Yutaka Furukawa, Takeshi Kimura. An Exploration of Optimal Anti-thrombotic Therapy after Drug-eluting Stent Implantation in Patients with Oral Anticoagulant: Insights from the SKIP-ASA Trial.
Kazuya Nagao, Takao Katoh ,Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Yodo Tamaki, Erika Yamamoto, Takeshi Kitai, Moritake Iguchi, Yuichi Kawase, Neiko Ozasa, Tsukasa Inada, Yukihito Satoh, Koichiro Kuwahara, Takeshi Kimura. Long-term Outcome of the Use of Inotropes and Vasodilators in the Contemporary Treatment of Acutely Decompensated Heart Failure.
Yuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, Shunsuke Saga, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kite Kim, Yukihito Satoh, Takeshi Kimura. Thrombolysis with Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolisms in the Real World: From the COMMAND VTE Registry.
西本 裕二, 山下 侑吾, 金 基泰, 森本 剛, 佐賀 俊介, 天野 秀生, 髙瀬 徹, 平森 誠一, 佐藤幸人, 木村 剛. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Cancer-associated Venous Thromboembolisms: From the COMMAND VTE Registry.
Koji Hanazawa, Takeshi Morimoto, Takeshi Kimura. Current Status of Fatal Arrhythmic Events in Japanese Patients with Ischemic Heart Disease.
Hiroyuki Hara, Hiroki Watanabe, Yuki Hori, Shingo Hirao, Naoki Kanemitsu, Takeshi Kimura. Comparison of 5-Year Outcomes after CABG and PCI for Severe Coronary Artery Disease in Patients with Previous Stroke.
Hiroyuki Hara, Hiroki Watanabe, Yuki Hori, Shingo Hirao, Naoki Kanemitsu, Takeshi Kimura. 5-Year Outcomes after Coronary Artery Bypass Grafting Using Single or Bilateral Internal Thoracic Artery for Complex Coronary Artery Disease.
Seiichi Hiramori, Yugo Yamashita, Takeshi Morimoto, Kenji Ando, Takeshi Kimura. Optimal Intensity of Warfarin Therapy for Secondary Prevention of Venous Thromboembolism: From the COMMAND VTE Registry.
Megumi Fukuyama, Seiko Ohno, Koichi Kato, Yusuke Fujii, Koichiro Takayama, Takeru Makiyama, Minoru Horie, Yoshihisa Nakagawa. Severe Phenotype in RYR2 Variant Carriers with Idiopathic Primary Arrhythmia Syndromes.
Megumi Fukuyama, Seiko Ohno, Junichi Ozawa, Yuta Yamamoto, Koichi Kato, Koichiro Takayama, Noriaki Yagi, Takeru Makiyama, Minoru Horie, Yoshihisa Nakagawa. Variable Severity in Long QT Syndrome Patients with Mutations in Genes Related with Calcium Handling.
村田 耕一郎, 山下 侑吾, 森本 剛, 縄田 隆三, 小野寺 知哉, 木村 剛. The Long-term Clinical Outcomes of Symptomatic Outpatients of Unprovoked Pulmonary Embolism: From the COMMAND VTE Registry.
Hiroki Watanabe, Takeshi Morimoto, Hiroki Shiomi, Takeshi Kimura. Revascularization Strategy in Patients with Multi-vessel Disease Including Chronic Total Occlusion.
Shintaro Matsuda, Kiyoto Nishi, Mikiko Ohno, Eiichiro Nishi. Nardilysin in adipocyte regulates adipose tissue inflammation and insulin sensitivity.
Koh Ono. Expression profile of microRNAs in cardiovascular diseases and their application as biomarkers.
Masahiro Kimura, Kazuki Matsushita, Takahiro Horie, Takeshi Kimura, Koh Ono. Elucidating the involvement and molecular functions of homeotic genes in the pathogenesis of pulmonary hypertension.
Hiromu Yanagisawa, Yasuaki Nakagawa, Kenji Moriuchi, Hideaki Inazumi, Hideyuki Kinoshita, Toshio Nishikimi, Miku Oya, Kazuwa Nakao, Koichiro Kuwahara, Takeshi Kimura. Endothelial CNP-GC-B system plays a protective role in the development of pulmonary hypertension.
Asami Kashiwa, Takeru Makiyama, Hirohiko Kohjitani, Thomas Maurissen, Yimin Wuriyanghai, Yuta Yamamoto, Jingshan Gao, Hai Huang, Tomohiko Imamura, Takanori Aizawa, Taisuke Ishikawa, Seiko Ohno, Futoshi Toyoda, Seiich Sato, Kazuhiro Takahashi, Yoshinori Yoshida, Knut Woltjen, Minoru Horie, Naomasa Makita, Takeshi Kimura. Inhibition of Late Sodium Current Attenuates Prolonged Action Potential Durations in CACNA1C-E1115K iPS Cell Model with Disrupted Cav1.2 ion Selectivity.
Ohno M, Nishi K, Hiraoka Y, Niizuma S, Matsuda S, Iwasaki H, Kimura K, and Nishi E. Nardilysin controls cardiac sympathetic innervation patterning through regulation of p75 neurotrophin receptor.